Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
Status:
Completed
Trial end date:
2019-06-14
Target enrollment:
Participant gender:
Summary
The purpose of this Pilot feasibility study is to find out the effect of different behavioral
treatments along with different duration of a drug called varenicline, on smoking behavior
and quitting smoking. Varenicline, also known as Chantix™, is an FDA-approved medication that
has been shown to help people quit smoking.
Phase:
Early Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
James and Esther King Biomedical Research Program Pfizer